Novastan argatroban small molecule thrombin inhibitor data

TXB announced positive Phase III data from its ARG-911 trial comparing Novastan treatment in 304 patients (160 with HIT

Read the full 193 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE